Jessica I W Morgan1. 1. Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Abstract
PURPOSE: Over the past 25 years, optical coherence tomography (OCT) and adaptive optics (AO) ophthalmoscopy have revolutionised our ability to non-invasively observe the living retina. The purpose of this review is to highlight the techniques and human clinical applications of recent advances in OCT and adaptive optics scanning laser/light ophthalmoscopy (AOSLO) ophthalmic imaging. RECENT FINDINGS: Optical coherence tomography retinal and optic nerve head (ONH) imaging technology allows high resolution in the axial direction resulting in cross-sectional visualisation of retinal and ONH lamination. Complementary AO ophthalmoscopy gives high resolution in the transverse direction resulting in en face visualisation of retinal cell mosaics. Innovative detection schemes applied to OCT and AOSLO technologies (such as spectral domain OCT, OCT angiography, confocal and non-confocal AOSLO, fluorescence, and AO-OCT) have enabled high contrast between retinal and ONH structures in three dimensions and have allowed in vivo retinal imaging to approach that of histological quality. In addition, both OCT and AOSLO have shown the capability to detect retinal reflectance changes in response to visual stimuli, paving the way for future studies to investigate objective biomarkers of visual function at the cellular level. Increasingly, these imaging techniques are being applied to clinical studies of the normal and diseased visual system. SUMMARY: Optical coherence tomography and AOSLO technologies are capable of elucidating the structure and function of the retina and ONH noninvasively with unprecedented resolution and contrast. The techniques have proven their worth in both basic science and clinical applications and each will continue to be utilised in future studies for many years to come.
PURPOSE: Over the past 25 years, optical coherence tomography (OCT) and adaptive optics (AO) ophthalmoscopy have revolutionised our ability to non-invasively observe the living retina. The purpose of this review is to highlight the techniques and human clinical applications of recent advances in OCT and adaptive optics scanning laser/light ophthalmoscopy (AOSLO) ophthalmic imaging. RECENT FINDINGS: Optical coherence tomography retinal and optic nerve head (ONH) imaging technology allows high resolution in the axial direction resulting in cross-sectional visualisation of retinal and ONH lamination. Complementary AO ophthalmoscopy gives high resolution in the transverse direction resulting in en face visualisation of retinal cell mosaics. Innovative detection schemes applied to OCT and AOSLO technologies (such as spectral domain OCT, OCT angiography, confocal and non-confocal AOSLO, fluorescence, and AO-OCT) have enabled high contrast between retinal and ONH structures in three dimensions and have allowed in vivo retinal imaging to approach that of histological quality. In addition, both OCT and AOSLO have shown the capability to detect retinal reflectance changes in response to visual stimuli, paving the way for future studies to investigate objective biomarkers of visual function at the cellular level. Increasingly, these imaging techniques are being applied to clinical studies of the normal and diseased visual system. SUMMARY: Optical coherence tomography and AOSLO technologies are capable of elucidating the structure and function of the retina and ONH noninvasively with unprecedented resolution and contrast. The techniques have proven their worth in both basic science and clinical applications and each will continue to be utilised in future studies for many years to come.
Authors: Monica F Chen; Toco Y P Chui; Paula Alhadeff; Richard B Rosen; Robert Ritch; Alfredo Dubra; Donald C Hood Journal: Invest Ophthalmol Vis Sci Date: 2015-01-08 Impact factor: 4.799
Authors: Jessica I W Morgan; Grace Han; Eva Klinman; William M Maguire; Daniel C Chung; Albert M Maguire; Jean Bennett Journal: Invest Ophthalmol Vis Sci Date: 2014-09-04 Impact factor: 4.799
Authors: Talisa E de Carlo; Marco A Bonini Filho; Adam T Chin; Mehreen Adhi; Daniela Ferrara; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed Journal: Ophthalmology Date: 2015-03-17 Impact factor: 12.079
Authors: Jacque L Duncan; Yuhua Zhang; Jarel Gandhi; Chiaki Nakanishi; Mohammad Othman; Kari E H Branham; Anand Swaroop; Austin Roorda Journal: Invest Ophthalmol Vis Sci Date: 2007-07 Impact factor: 4.799
Authors: Min Chen; Robert F Cooper; Grace K Han; James Gee; David H Brainard; Jessica I W Morgan Journal: Biomed Opt Express Date: 2016-11-03 Impact factor: 3.732
Authors: Richard B Rosen; Jorge S Andrade Romo; Brian D Krawitz; Shelley Mo; Amani A Fawzi; Rachel E Linderman; Joseph Carroll; Alexander Pinhas; Toco Y P Chui Journal: Am J Ophthalmol Date: 2019-01-26 Impact factor: 5.258
Authors: Stephen A Burns; Ann E Elsner; Kaitlyn A Sapoznik; Raymond L Warner; Thomas J Gast Journal: Prog Retin Eye Res Date: 2018-08-27 Impact factor: 21.198
Authors: William S Tuten; Robert F Cooper; Pavan Tiruveedhula; Alfredo Dubra; Austin Roorda; Nicolas P Cottaris; David H Brainard; Jessica I W Morgan Journal: J Vis Date: 2018-08-01 Impact factor: 2.240
Authors: Jessica I W Morgan; Grace K Vergilio; Jessica Hsu; Alfredo Dubra; Robert F Cooper Journal: Transl Vis Sci Technol Date: 2018-06-22 Impact factor: 3.283